Compound ID | 427
Class: Beta-lactam (cephalosporin)
| Spectrum of activity: | Gram-positive |
| Details of activity: | Was tested against 473 clinical isolates and it was found there was a preference for Gram positive bacteria. The MICs were lower than both cefdinir and cefpirome against Streptococcus pyogens 308A, S. aureus 285 and Enterococcus faecium MD 8b. |
| Description: | Park SH, Park SY, Kim DY, et al. Novel 3-isoxazolylvinyl Cephalosporins: II. Antibacterial activities against clinical isolates and pharmacokinetics in mice. 37th-Intersci-Conf-Antimicrobial-Agents-Chemother 1997; 177. |
| Institute where first reported: | Parke Davis Pharmaceutical Research (Pfizer, USA) |
| Year first mentioned: | 1997 |
| Highest developmental phase: | Preclinical |
| Development status: | Inactive |
| Chemical structure(s): | |||||||||||
|
|
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/23693945 |
| Citation: |